- Home
- / Verici Dx
Verici Dx
Stock Price
£0
2024-10-29
Market Capitalization
£8.5 M
2024-10-29
Revenue
$3.3 M
FY, 2024
Verici Dx Summary
Company Summary
- Overview
- Verici Dx is an immuno-diagnostics development company. It offers treatment for immunological, transcriptomic, clinical, and pathological data to define a personalized risk and diagnosis of the kidney.
- Type
- Public
- Status
- Active
- Founded
- 2019
- Website
- https://vericidx.com
- Cybersecurity rating
Table of Contents
Verici Dx Financials
Summary Financials
- Revenue (H1, 2025)
- $1.9M
- Gross profit (H1, 2025)
- $1.6M
- Net income (H1, 2025)
- ($3.1M)
- Cash (H1, 2025)
- $467.0K
- EBIT (H1, 2025)
- ($3.0M)
- Enterprise value
- $8.3M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026